SINGAPORE, 14 April 2026 – Supratechnic (S) Pte Ltd has secured sole nationwide distribution rights for Swiss air quality specialist IQAir in Singapore, marking a significant expansion of its healthcare solutions portfolio amid rising demand for premium indoor air quality systems.
The appointment formalises a long-standing partnership between the two companies and positions Supratechnic as the exclusive distributor of IQAir’s clinical-grade air purification systems across the Singapore market.
Strategic Expansion into Clinical-Grade Air Solutions
The exclusive distributorship strengthens Supratechnic’s healthcare division, enabling it to deliver advanced air filtration technologies widely used in hospitals and critical care environments.
Founded in 1963, IQAir is globally recognised for its HyperHEPA filtration technology, capable of capturing ultrafine particles down to 0.003 microns, significantly outperforming conventional air purifiers in filtering pollutants such as:
- Viruses and bacteria
- Tobacco smoke
- Combustion particles
The brand has been deployed in high-risk environments, including during the SARS and COVID-19 outbreaks, reinforcing its clinical credibility.
Launch of Suprayi E-Commerce Platform
Alongside the distribution milestone, Supratechnic has launched Suprayi, a dedicated e-commerce platform designed to provide access to clinically proven health solutions.
The platform serves as:
- An official sales channel for IQAir products
- A technical advisory hub for customers
- A provider of local warranty and after-sales support
The launch reflects a strategic shift toward digital distribution, enabling broader market reach across corporate, healthcare, and residential segments.
Capturing a Structural Growth Trend
The move comes as Singapore’s air quality landscape undergoes a structural shift, driven by:
- Seasonal transboundary haze
- Urban emissions and indoor pollutants
- Increased awareness of health and air safety
The Singapore air purifier market, valued at approximately US$199 million in 2024, is projected to reach US$280 million by 2030, highlighting strong and sustained demand growth.
Industry experts increasingly view clean air not as a discretionary product, but as essential infrastructure particularly in densely populated urban environments.
Building on a Long-Term Partnership
Supratechnic’s CEO Melvin Tan noted that the appointment reflects years of investment in service infrastructure, technical expertise, and after-sales capabilities.
“Our responsibility now is to deliver consistently at the highest standards, ensuring customers receive reliable, clinically proven solutions supported by strong local expertise,” he said.
IQAir CEO Jens Hammes added that the partnership, which dates back to 2004, demonstrates strong alignment in mission and execution.
Positioning at the Centre of Demand
With sole distribution rights secured at a time of accelerating demand, Supratechnic is positioning itself at the intersection of:
- Healthcare infrastructure
- Environmental technology
- Consumer wellness
The integration of distribution, service capability, and digital platform through Suprayi creates a comprehensive ecosystem designed to capture growth across multiple segments.
Investor and Industry Perspective
For investors, the development highlights a rising structural theme:
Indoor air quality is emerging as a critical segment within the broader healthcare and environmental technology space.
As awareness grows and regulatory standards tighten, demand for clinically validated solutions is expected to increase particularly in urban markets across Asia.
Supratechnic’s exclusive partnership with IQAir places it in a strong position to benefit from this long-term trend.
